scispace - formally typeset
Journal ArticleDOI

Therapeutic potential of resveratrol: the in vivo evidence.

Joseph A. Baur, +1 more
- 01 Jun 2006 - 
- Vol. 5, Iss: 6, pp 493-506
Reads0
Chats0
TLDR
A comprehensive and critical review of the in vivo data on resveratrol is provided, and its potential as a therapeutic for humans is considered.
Abstract
Resveratrol, a constituent of red wine, has long been suspected to have cardioprotective effects. Interest in this compound has been renewed in recent years, first from its identification as a chemopreventive agent for skin cancer, and subsequently from reports that it activates sirtuin deacetylases and extends the lifespans of lower organisms. Despite scepticism concerning its bioavailability, a growing body of in vivo evidence indicates that resveratrol has protective effects in rodent models of stress and disease. Here, we provide a comprehensive and critical review of the in vivo data on resveratrol, and consider its potential as a therapeutic for humans.

read more

Citations
More filters
Journal ArticleDOI

Resveratrol, sirtuins, and the promise of a DR mimetic

TL;DR: In rodents, resveratrol improves health, and prevents the early mortality associated with obesity, but its precise mechanism of action remains a subject of debate, and extension of normal lifespan has not been observed.
Journal ArticleDOI

Oxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases

TL;DR: Here, it is reviewed how epigenetics takes part in the control of stress stimuli and the mechanisms of ageing physiology and physiopathology to help the development of anti-ageing therapies.
Journal ArticleDOI

Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells.

TL;DR: Evidence is provided demonstrating the antitumor effect of trans-resveratrol via a ROS-dependent apoptosis pathway in colorectal carcinoma through the production of superoxide anions in the mitochondria of cells undergoing apoptosis.
Journal ArticleDOI

Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease

TL;DR: Compounds 5d and 10d are potential lead compounds for AD therapy and are capable of disassembling the highly structured Aβ fibrils generated by self- and Cu(II)-induced Aβ aggregation.
References
More filters
Journal ArticleDOI

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

TL;DR: Experiments with guinea-pig lung suggest that some of the therapeutic effects of sodium salicylate and aspirin-like drugs are due to inhibition of the synthesis of prostaglandins.
Journal ArticleDOI

Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

TL;DR: It is suggested that resveratrol, a common constituent of the human diet, merits investigation as a potential cancer chemopreventive agent in humans.
Journal ArticleDOI

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

TL;DR: The potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD+, and increases cell survival by stimulating Sirt1-dependent deacetylation of p53.
Journal ArticleDOI

Wine, alcohol, platelets, and the French paradox for coronary heart disease

TL;DR: Data from Caerphilly, Wales, show that platelet aggregation, which is related to CHD, is inhibited significantly by alcohol at levels of intake associated with reduced risk of CHD.
Journal ArticleDOI

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

TL;DR: A balance between formation of anti- and pro-aggregatory substances by enzymes could also contribute to the maintenance of the integrity of vascular endothelium and explain the mechanism of formation of intra-arterial thrombi in certain physiopathological conditions.
Related Papers (5)